SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001116502-03-001633
Filing Date
2003-08-22
Accepted
2003-08-22 12:08:28
Documents
1
Group Members
HAROLD R. WERNERHEALTHCARE PARTNERS II, L.P.HEALTHCARE PARTNERS III, L.P.HEALTHCARE PARTNERS IV, L.P.HEALTHCARE VENTURES II, L.P.HEALTHCARE VENTURES III, L.P.HEALTHCARE VENTURES IV, L.P.JAMES H. CAVANAUGH, PH.D.JOHN W. LITTLECHILDWILLIAM CROUSE

Document Format Files

Seq Description Document Type Size
1 DIACRIN, INC. SCHEDULE 13D AMEND 3 diacrinsc13da.txt SC 13D/A 41447
  Complete submission text file 0001116502-03-001633.txt   44028
Mailing Address TWIN TOWERS AT METRO PARK 379 THORNALL AVENUE EDISON NJ 08837
Business Address TWIN TOWERS AT METRO PARK 379 THORNALL AVENUE EDISON NJ 08837 9089064613
HEALTHCARE VENTURES II LP (Filed by) CIK: 0000859649 (see all company filings)

IRS No.: 223015728 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 0000

Mailing Address BLDG 96 13TH ST CHARLESTOWN NAVY YARD CHARLESTOWN MA 02129
Business Address BLDG 96, 13TH ST CHARLESTOWN NAVY YARD CHARLESTOWN MA 02129 6172429100
DIACRIN INC /DE/ (Subject) CIK: 0000887137 (see all company filings)

IRS No.: 223016912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-43238 | Film No.: 03861791
SIC: 2836 Biological Products, (No Diagnostic Substances)